Perez-Segura P - Search Results

1

Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.

Caldés T, Perez-Segura P, Tosar A, de La Hoya M, Diaz-Rubio E. Caldés T, et al. Teratog Carcinog Mutagen. 2000;20(5):283-91. Teratog Carcinog Mutagen. 2000. PMID: 10992275

2

Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.

González-Larriba JL, Garcia Carbonero I, Sastre Valera J, Perez Segura P, Diaz-Rubio E. González-Larriba JL, et al. Oncology (Williston Park). 1997 Sep;11(9 Suppl 10):90-7. Oncology (Williston Park). 1997. PMID: 9348577 Clinical Trial.

3

Paclitaxel plus vinorelbine in metastatic breast Ca patients with contraindications to receive anthracyclines.

Martin M, Casado A, Perez Segura P, Garcia Carbonero I, Diaz-Rubio E. Martin M, et al. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):28-30. Oncology (Williston Park). 1998. PMID: 9516600 Free article.

4

Low frequency of microsatellite instability in sporadic breast cancer.

Caldes T, Perez-Segura P, Tosar A, De La Hoya M, Diaz-Rubio E. Caldes T, et al. Int J Oncol. 2000 Jun;16(6):1235-42. doi: 10.3892/ijo.16.6.1235. Int J Oncol. 2000. PMID: 10812001

5

New mutation in the hMSH2 gene in a Spanish Muir-Torre syndrome.

Caldés T, Godino J, Perez-Segura P, de la Hoya M, Diaz-Rubio E, Benito M. Caldés T, et al. Am J Gastroenterol. 2000 Sep;95(9):2389-90. doi: 10.1111/j.1572-0241.2000.02344.x. Am J Gastroenterol. 2000. PMID: 11007253 No abstract available.

6

Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

de la Hoya M, Pérez-Segura P, Van Orsouw N, Díaz-Rubio E, Caldés T. de la Hoya M, et al. Int J Cancer. 2001 Jan 1;91(1):137-40. doi: 10.1002/1097-0215(20010101)91:1<137::aid-ijc1020>3.0.co;2-r. Int J Cancer. 2001. PMID: 11149413 No abstract available.

7

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T. de la Hoya M, et al. Int J Cancer. 2002 Feb 1;97(4):466-71. doi: 10.1002/ijc.1627. Int J Cancer. 2002. PMID: 11802208

8

Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.

Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E. Caldes T, et al. Int J Cancer. 2002 Apr 10;98(5):774-9. doi: 10.1002/ijc.10240. Int J Cancer. 2002. PMID: 11920650

9

A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes.

Caldes T, de la Hoya M, Tosar A, Sulleiro S, Godino J, Ibañez D, Martin M, Perez-Segura P, Diaz-Rubio E. Caldes T, et al. J Med Genet. 2002 Aug;39(8):e44. doi: 10.1136/jmg.39.8.e44. J Med Genet. 2002. PMID: 12161611 Free PMC article. No abstract available.

10

Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.

García-Sáenz JA, Martín M, Casado A, Pérez-Segura P, Manrique I, Flores L, Macias JA, Cámara JC, Perezagua C, Díaz-Rubio E. García-Sáenz JA, et al. Rev Esp Quimioter. 2002 Sep;15(3):257-63. Rev Esp Quimioter. 2002. PMID: 12582429 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters